Eagle Health Holdings Limited (ASX: EHH) (referred to as "Eagle" or "Company") is honored to announce that on November 28, 2019, it has successfully received a fully paid commitment to all qualified senior and professional investors. Ordinary shares (new shares), all investors are unrelated parties, and a total of 1 million Australian dollars (without deduction of expenses) (placement) has been raised.
In accordance with the company’s existing placement capacity as specified in the Australian Securities Exchange’s Listing Rules 7.1, 10,000,000 new shares were issued by placement at a price of 0.10 Australian dollars per share. Compared with the closing price of the last trading day, there is a 9.1% discount; compared with the average price of Eagle's trading volume (VWAP) in the past 15 days, there is a 6.8% discount.
The funds raised will be used in Australia's new product line and investment evaluation work, market research and end-user analysis, the development of new and existing brands and daily operations.
The new shares will have the same status as the company's existing fully paid ordinary shares. The placement does not require shareholder approval, because according to the ASX listing rules, the issuance of new shares is within the company's existing placement capabilities.
The new shares are expected to be issued within a week from December 2, 2019, at which time the company will submit Appendix 3B. The company did not arrange a placement manager in this placement.